Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    C21005
Show Display Options
Rank Status Study
1 Completed Study Comparing Orteronel Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Orteronel + prednisone;   Drug: Placebo + prednisone

Indicates status has not been verified in more than two years